According to the most recent analysis by Emergen Research, the global market for anticonvulsants was valued at USD 18.16 billion in 2021 and is predicted to grow at a rate of 2.3 percent in terms of revenue during the forecast period.
According to the most recent analysis by Emergen Research, the global market for anticonvulsants was valued at USD 18.16 billion in 2021 and is predicted to grow at a rate of 2.3 percent in terms of revenue during the forecast period. Major factors influencing market revenue growth include rising high-value investments in the healthcare sector and an increase in Research & Development (R&D) initiatives by many major pharmaceutical companies for improvement in anticonvulsant therapy tolerability and medicines. The market for anticonvulsants is expanding due to rising rates of epilepsy and other neurological illnesses as well as a growing need for pain relief due to migraines.
Anticonvulsants are prescription medications that are primarily used to treat psychiatric illnesses and epileptic seizures. There is a high need for anticonvulsants due to rising bipolar prevalence and associated diseases, such as Attention Deficit Hyperactivity Disorder, severe temper dysregulation, recurrent violence, and intellectual impairment (ADHD).
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1213
The National Institute of Mental Health estimates that 52.9 million adults in the United States, or about 21 percent of the population, will have mental disease in 2020. Additionally, it was calculated that 7 million people, or nearly 2.8 percent of American adults, suffer from bipolar disorder. The market is expanding due to the usage of anticonvulsant drugs to treat migraines and neuropathic pain. One of the most frequently prescribed drugs for kids with recurrent bipolar disorder is anticonvulsants. Some of the FDA-approved anticonvulsants, particularly for the maintenance treatment of bipolar disorders, have demonstrated efficacy as mood stabilisers in adults, including valproate, carbamazepine, and lamotrigine. Anticonvulsants are used in seizure disorders and epilepsy because they maintain the normal level of nerve cell impulses, preventing them from becoming excessive and out of control.
anticonvulsant drugs that have received approval from the United States Food and Drug Administration (USFDA) and the European Medical Agency (EMA) for the treatment of epilepsy, fibromyalgia, migraine, and neuropathic pain. However, the side effects of anticonvulsant medications, which frequently include drowsiness, fatigue, nausea, tremor, rash, and weight gain, are preventing the market from expanding.
Traditional antiepileptic medications may inhibit sodium channels or improve GABA (gamma-aminobutyric acid) action. Many antiepileptic medications have a variety of different or ambiguous modes of action. The disturbance in the electrical activity of the brain is what causes epileptic seizures. Anticonvulsants are also used to control neuropathic pain and to treat bipolar disorder. In animal models of epilepsy, some anticonvulsants shown antiepileptogenic properties. They can either stop or stop the progression of epilepsy, or they can prevent the onset of epilepsy.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/anticonvulsants-market
Some Key Highlights From the Report
- The AMPA division contributed for biggest revenue share in 2021. One of the main factors influencing this segment’s revenue growth is the use of AMPA in the treatment of partial on-set seizures in epilepsy patients. Drugs bind to the AMPA receptor found in the central nervous system (CNS) and block it. The calcium-permeable (CP-AMPARs) and calcium-impermeable (CI-AMPARs) subtypes of AMPARs play different functions in the maintenance of equilibrium in the excitation-inhibition of the brain, respectively.
- In 2021, the hospital pharmacy market had a sizable revenue share. The presence of doctors and other medical experts in both developed and emerging nations, as well as the rising number of hospital pharmacies for neurological disorders, are a few of the major drivers boosting this segment’s revenue growth. This market is expanding as a result of better medical infrastructure, including facilities and supplies, and high-value funding for the creation of novel pharmaceuticals.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1213
- Second-generation anticonvulsant drugs’ improved efficacy, fewer side effects, and better tolerance are the main drivers boosting this segment’s sales growth. The market for second-generation medications is also rising as a result of the absence of blood level monitoring requirements. This category is also growing as a result of the high demand for anticonvulsant medications used alone or in conjunction with other treatments.
- In 2021, the market in North America accounted for the biggest revenue share. Numerous neurological illnesses are becoming more prevalent, and major pharmaceutical companies are boosting their R&D expenditures in the area of anticonvulsant drug development. These reasons are what are causing the market in this sector to see revenue growth. The market for anticonvulsants is also growing rapidly as a result of increased government and pharmaceutical company collaborations and the approval of more new, innovative medications.
- The GSK Group of Firms, Novartis AG, Pfizer Inc., UCB S.A, Johnson & Johnson Services, Inc., Abbott, Sunovion Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Eisai Co., Ltd., and Sanofi are a few of the significant companies in the global market study.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1213
Emergen Research has segmented the global anticonvulsants market based on drug type, drug generation, distribution channel, and region:
- Drug Type Outlook (Revenue, USD Billion; 2019-2030)
- α-Amino-3-Hydroxy-5-Methyl-4-isoxazolepropionic Acid (AMPA)
- N-Methyl-D-Aspartate Receptor (NMDAR)
- Carbamate Anticonvulsants
- Barbiturate
- Carbonic Anhydrase Inhibitor
- Triazine
- Others
- Drug Generation Outlook (Revenue, USD Billion; 2019-2030)
- First Generation
- Second Generation
- Third Generation
- Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of Middle East & Africa
- North America
Make an Inquiry Before Buying@ https://www.emergenresearch.com/purchase-enquiry/1213
Read Latest Reports Published by Emergen Research:
Decentralized Finance Platforms Market Size, Share, Trends, By Component (Blockchain Technology, Decentralized Applications (dApps), Smart Contracts), By Application (Assets Tokenization, Compliance & Identity, Marketplaces & Liquidity), and By Region Forecast to 2028.
DNA Methylation Market, By Technology (Bisulfite DNA Modification, Others), By Application (DNA Sequencing, Others), By End-Use (Biotechnology Industry, Others), By Product (Enzymes, Reagents, Kits, Others), and By Region Forecast to 2030.
Orthopedics Diagnostic Devices Market Size, Share, Trends, By Product (X-ray Systems, Fluoroscopy, Doppler Ultrasound, Others), By Type (Standalone and Point of Care), By Age Group, By Application, By End User, and By Region Forecast to 2030.
Microbial Bioremediation Market, By Pollutants (Organic Pollutants and Inorganic Pollutants), By Organisms, By Type, By Technology, By Application, By End-use, and By Region Forecast to 2030.
Omega 3 PUFA Market By Type (Docosahexaenoic Acid[DHA], Eicosapentaenoic Acid [EPA], Alpha-Linolenic Acid [ALA] and others), By Source [Marine, Plant], By Application, and By Region Forecast to 2028.
Flexible Organic Light Emitting Diode Market By Technology (Passive-Matrix OLED (PMOLED), Active-Matrix OLED (AMOLED)), By Flexibility Type (Curved Display, Foldable Display), By Application, By End-use, and By Region Forecast to 2030.
Biobetters Market By Drug Class (Erythropoietin biobetters, Insulin Biobetters), By Application (Cancer, Diabetes, Renal, Neurodegenerative), By Route of Administration (Subcutaneous, Oral), By Distribution Channel, and By Region Forecast to 2030.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-anticonvulsants-market